Compare WVE & NYAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WVE | NYAX |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | Singapore | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.1B |
| IPO Year | 2015 | 2022 |
| Metric | WVE | NYAX |
|---|---|---|
| Price | $13.35 | $57.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 5 |
| Target Price | $31.47 | ★ $49.50 |
| AVG Volume (30 Days) | ★ 2.2M | 10.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,704,000.00 | N/A |
| Revenue This Year | N/A | $25.96 |
| Revenue Next Year | $119.93 | $19.69 |
| P/E Ratio | ★ N/A | $89.78 |
| Revenue Growth | ★ 149.43 | N/A |
| 52 Week Low | $5.28 | $32.38 |
| 52 Week High | $21.73 | $60.77 |
| Indicator | WVE | NYAX |
|---|---|---|
| Relative Strength Index (RSI) | 47.54 | 56.68 |
| Support Level | $12.53 | $42.63 |
| Resistance Level | $14.56 | $58.14 |
| Average True Range (ATR) | 0.79 | 1.56 |
| MACD | 0.01 | 0.48 |
| Stochastic Oscillator | 23.84 | 79.78 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.